News
Ready to transform your body? It's possible with this program's personalized care, telehealth consultations, and semaglutide ...
Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for cardiometabolic diseases and GI oncological indications announced today that it ...
2h
Zacks Investment Research on MSNIs Eli Lilly Stock a Portfolio Must-Have Pre-Q1 Earnings? (Revised)Eli Lilly and Company LLY will report its first-quarter earnings on May 1, before market open. The Zacks Consensus Estimate ...
6h
Zacks Investment Research on MSNIs Eli Lilly Stock a Portfolio Must-Have Pre-Q2 Earnings?Eli Lilly and Company LLY will report its first-quarter earnings on May 1, before market open. The Zacks Consensus Estimate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results